Stock screenerAll disclosures →
EDGAR →
DGX
Conviction 79HealthcareScan · Mon, Jul 20, 2026DGX$207.56-1.48%
ResistanceSupportVol 14Insider sellCongress buyCongress sellVol MA14 934.16K
Apr 20May 6May 26Jun 11Jul 1Jul 20
WSB mentions · 24h changelatest +0.00%· 1 mentions
Apr 20May 6May 26Jun 11Jul 1Jul 20
Price207.56
Change-1.48%
Gap-0.46%
Rel volume2.26×
Avg volume943.76K
Avg $ vol196.08M
SMA 20207.93
SMA 50200.14
SMA 200191.99
Price vs 50+3.71%
Price vs 200+8.11%
MA stackbullish
50/200 cross—
Supertrenddown · 218.04
RSI (14)53
MACD hist-0.67
MACD crossbear · 6d
Stoch %K / %D36 / 45
ADX (14)23
+DI / −DI28 / 22
RSI divergence—
MACD divergence—
ATR %+2.41%
ADR %2.29%
52w high216.02
52w low166.45
From 52w high-3.92%
Above 52w low+24.70%
New 52w highNo
SqueezeOff
Bollinger width10.70%
%B0.48
Donchian pos55.74%
Donchian high219.20
Donchian low192.90
AVWAP (52w high)208.13
vs AVWAP high-0.28%
AVWAP (52w low)189.10
vs AVWAP low+9.76%
OBV trendDown
Chaikin MF (20)-0.02
Today vs 20d2.26×
Avg vol (14d)934.16K
Avg vol (20d)943.76K
Avg $ vol (20d)196.08M
Market cap22.98B
RS 3m (vs SPY)+4.11%
RS 6m (vs SPY)+5.13%
RS line new highNo
Trend template7/8
Technical rank74.8
1 week+0.10%
1 month+4.96%
3 months+6.43%
6 months+9.09%
1 year+23.42%
YTD+19.43%
P/E23.16
P/B3.12
P/S2.08
P/FCF16.91
EPS8.75
Div yield1.54%
ROE13.47%
ROA5.95%
Debt/Eq0.77
Current1.18
EV/EBITDA13.29
Gross margin32.92%
Net margin8.99%
Rev growth11.78%
EPS growth13.89%
Price target228.86
Target upside10.26%
Analyst ratingBuy
Institutional107.53%
Ent. value28.25B
Revenue2.9B
Net income252M
Gross profit—
Free cash flow1.36B
IndustrySERVICES-MEDICAL LABORATORIES
ExchangeNYSE
Shares out110.7M
Employees57K
ListedTue, Dec 17, 1996
Free float109.45M
Float %99.6%
Short interest3.73M
Days to cover3.8d
Short volume81.4%
Squeeze score61 / 100
Next earningsThu, Jul 23, 2026 · pre-mkt (3d)
EPS forecast$2.81 · 9 est
Last EPS vs est$2.50 vs $2.37
Last surprise+5.5% beat
Setup gradeA
Conviction79 / 100
Pattern quality—
Tech rank74.8 / 100
Group rank23 / 100
Status laneNo active setup
Setup direction—
Pattern family
Resistance214.98
Support191.92
Days since event—
Candle confirm—
News sentiment—
Financials as of Tue, Mar 31, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in DGX · 4 recent
| Member | Side | Amount | Traded | Filed | PTR |
|---|---|---|---|---|---|
RK Rohit Khanna house · CA | Other | — | — | 2026-03-09 | |
Julia Letlow house · LA · traded 2025-07-24 | Sell | $1K–$15K | 2025-07-24 | 2025-08-11 | |
Carol Devine Miller house · R · WV · traded 2025-03-10 | Sell | $1K–$15K | 2025-03-10 | 2025-04-11 | |
Thomas H Tuberville senate · traded 2024-01-03 | Sell | $15K–$50K | 2024-01-03 | 2024-02-14 |
Insider activity
SEC Form 4 transactions in DGX · 5 buys · 4 sells
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
KUPPUSAMY KARTHIK SVP, Clinical Solutions · Common Stock · 2026-06-04 | Sell | 8.15K | $1.6M | 2026-06-04 | 2026-06-08 |
KUPPUSAMY KARTHIK SVP, Clinical Solutions · Common Stock · 2026-06-04 | Exercise | 3.32K | $424K | 2026-06-04 | 2026-06-08 |
KUPPUSAMY KARTHIK SVP, Clinical Solutions · Common Stock · 2026-06-04 | Other | — | — | 2026-06-04 | 2026-06-08 |
KUPPUSAMY KARTHIK SVP, Clinical Solutions · Non-Qualifed Stock Option (right to buy) · 2026-06-04 | Exercise | 4.83K | $588K | 2026-06-04 | 2026-06-08 |
KUPPUSAMY KARTHIK SVP, Clinical Solutions · Non-Qualifed Stock Option (right to buy) · 2026-06-04 | Exercise | 3.32K | $424K | 2026-06-04 | 2026-06-08 |
KUPPUSAMY KARTHIK SVP, Clinical Solutions · Common Stock · 2026-06-04 | Exercise | 4.83K | $588K | 2026-06-04 | 2026-06-08 |
Davis J. E. CEO and President · Common Stock · 2026-06-01 | Sell | 10K | $1.9M | 2026-06-01 | 2026-06-02 |
Gregg Vicky B Director · Common Stock · 2026-05-20 | Grant | 1.14K | $0 | 2026-05-20 | 2026-05-21 |
Diaz Luis Director · Common Stock · 2026-05-20 | Grant | 1.14K | $0 | 2026-05-20 | 2026-05-21 |
Doi Tracey Director · Common Stock · 2026-05-20 | Grant | 1.14K | $0 | 2026-05-20 | 2026-05-21 |
SEC filings
EDGAR filings in DGX · 2 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.
Start free — 14-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.